Background: Several studies suggested cross talk among components of hemostasis, inflammation, and immunity pathways in the pathogenesis, neurodegeneration, and occurrence of cerebral microbleeds (CMBs) in multiple sclerosis (MS). Objectives: This study aimed to evaluate the combined contribution of the hemostasis inhibitor protein C (PC) and chemokine C-C motif ligand 18 (CCL18) levels to brain atrophy in MS and to identify disease-relevant correlations among circulating levels of hemostasis inhibitors, chemokines, and adhesion molecules, particularly in CMB occurrence in MS. Methods: Plasma levels of hemostasis inhibitors (ADAMTS13, PC, and PAI1), CCL18, and soluble adhesionmolecules (sNCAM, sICAM1, sVCAM1, and sVAP1) were evaluated by mu...
Background and purpose: The aim was to investigate the plasma levels of hemostasis components in mul...
Cerebral microbleeds (CMBs) are defined as small and hypointense areas which could correspond to clu...
Inflammatory mediators have crucial roles in leukocyte recruitment and subsequent central nervous sy...
Background: Several studies suggested cross talk among components of hemostasis, inflammation, and i...
Background: Several studies suggest the crosstalk of coagulation with inflammation and immunity in t...
Background: Several studies suggested crosstalk among components of hemostasis, inflammation and imm...
Background: The progressive failure of blood–brain barrier (BBB) integrity, which may have the patho...
Objective: To investigate the association between plasma levels of hemostasis inhibitors and MRI out...
Background and purpose: The involvement of protein C (PC) pathway components in multiple sclerosis (...
Objective: To investigate the association between plasma levels of hemostasis inhibitors and MRI out...
Objective: To investigate correlations of C-C motif ligand 18 (CCL18) levels with clinical and MRI m...
Background: Chemokine ligands and co-stimulatory factors are involved in macrophage activation and d...
Objective: To investigate correlations of C-C motif ligand 18 (CCL18) levels with clinical and MRI m...
Background and purpose: The aim was to investigate the plasma levels of hemostasis components in mul...
Cerebral microbleeds (CMBs) are defined as small and hypointense areas which could correspond to clu...
Inflammatory mediators have crucial roles in leukocyte recruitment and subsequent central nervous sy...
Background: Several studies suggested cross talk among components of hemostasis, inflammation, and i...
Background: Several studies suggest the crosstalk of coagulation with inflammation and immunity in t...
Background: Several studies suggested crosstalk among components of hemostasis, inflammation and imm...
Background: The progressive failure of blood–brain barrier (BBB) integrity, which may have the patho...
Objective: To investigate the association between plasma levels of hemostasis inhibitors and MRI out...
Background and purpose: The involvement of protein C (PC) pathway components in multiple sclerosis (...
Objective: To investigate the association between plasma levels of hemostasis inhibitors and MRI out...
Objective: To investigate correlations of C-C motif ligand 18 (CCL18) levels with clinical and MRI m...
Background: Chemokine ligands and co-stimulatory factors are involved in macrophage activation and d...
Objective: To investigate correlations of C-C motif ligand 18 (CCL18) levels with clinical and MRI m...
Background and purpose: The aim was to investigate the plasma levels of hemostasis components in mul...
Cerebral microbleeds (CMBs) are defined as small and hypointense areas which could correspond to clu...
Inflammatory mediators have crucial roles in leukocyte recruitment and subsequent central nervous sy...